, Volume 13, Issue 3, pp 369–374 | Cite as

Increased placental growth factor (PlGF) concentrations in children and adolescents with obesity and the metabolic syndrome

  • Panagiota PervanidouEmail author
  • Giorgos Chouliaras
  • Athanassios Akalestos
  • Despoina Bastaki
  • Filia Apostolakou
  • Ioannis Papassotiriou
  • George P. Chrousos
Research paper


OBJECTIVE: Childhood obesity and the Metabolic Syndrome (MetS) are associated with an increased risk for early onset endothelial dysfunction and atherosclerosis. Placental growth factor (PlGF), a member of the vascular endothelial growth factor family, plays an important role in atherosclerosis by stimulating angiogenesis and atherogenic migration of monocytes/macrophages into the arterial wall. The aim of this study was to investigate differences in circulating PlGF concentrations between children with obesity/metabolic syndrome and non-obese children. We have previously shown increased high-sensitivity troponin (hs-TnT) concentrations in children with MetS from the same cohort. DESIGN: Fifty-seven obese (49 without and 8 with MetS) and 25 non-obese children (controls) were assessed at the Childhood Obesity Clinic of our Department. Obesity was defined using the IOTF criteria. MetS was defined based on the IDF criteria. PlGF was measured using electrochemiluminescence methodology. RESULTS: Mean PIGF concentrations of obese children were significantly higher (p=0.048) compared with those of the controls. Analysis of the three groups, the obese (without MetS), the MetS and the control, demonstrated a significant difference in PlGF concentrations (p=0.035). Subgroup analysis revealed increased PlGF concentrations in children with the MetS compared to the controls (p=0.009). Troponin had a significant positive correlation with PlGF overall (p=0.003) and in the obese group (p=0.046). CONCLUSIONS: Increased serum concentrations of PlGF, a biomarker of angiogenesis, are found in obese children with the MetS compared to non-obese controls, whereas PlGF correlated positively with troponin. Longitudinal studies may reveal the prognostic role of this biomarker in the progression of atherosclerosis in obese children with the MetS.

Key words

Angiogenesis Cardiovascular risk Children Metabolic syndrome Obesity PlGF Troponin 


  1. 1.
    Bridger T, 2009 Childhood obesity and cardiovascular disease. Paediatr Child Health 14: 177–182.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Kassi E, Pervanidou P, Kaltsas G, Chrousos G, 2011 Metabolic syndrome: definitions and controversies. BMC Med 9: 48.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Carmeliet P, 2003 Angiogenesis in health and disease. Nat Med 9: 653–660.CrossRefGoogle Scholar
  4. 4.
    Sandhofer A, Tatarczyk T, Kirchmair R, et al, 2009 Are plasma VEGF and its soluble receptor sFlt-1 atherogenic risk factors? Cross-sectional data from the SAPHIR study. Atherosclerosis 206: 265–269.CrossRefGoogle Scholar
  5. 5.
    Dewerchin M, Carmeliet P, 2012 PlGF: a multitasking cytokine with disease-restricted activity. Cold Spring Harb Perspect Med doi: 10.1101/cshperspect.a011056 (in press).Google Scholar
  6. 6.
    Cassidy A, Chiuve SE, Manson JE, Rexrode KM, Girman CJ, Rimm EB, 2009 Potential role for plasma placental growth factor in predicting coronary heart disease risk in women. Arterioscler Thromb Vasc Biol 29: 134–139.CrossRefGoogle Scholar
  7. 7.
    Pelisek J, Well G, Reeps C, et al, 2012 Neovascularization and angiogenic factors in advanced human carotid artery stenosis. Circ J 76: 1274–1282.CrossRefGoogle Scholar
  8. 8.
    Hausman GJ, Richardson RL, 2004 Adipose tissue angiogenesis. J Anim Sci 82: 925–934.CrossRefGoogle Scholar
  9. 9.
    Makey KL, Patterson SG, Robinson J, et al, 2013 Increased plasma levels of soluble vascular endothelial growth factor receptor 1 (sFlt-1) in women by moderate exercise and increased plasma levels of vascular endothelial growth factor in overweight/obese women. Eur J Cancer Prev 22: 83–89.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Siervo M, Ruggiero D, Sorice R, et al, 2012 Body mass index is directly associated with biomarkers of angiogenesis and inflammation in children and adolescents. Nutrition 28: 262–266.CrossRefGoogle Scholar
  11. 11.
    Kaess BM, Pedley A, Massaro JM, et al, 2012 Relation of vascular growth factors with CT-derived measures of body fat distribution: the Framingham Heart Study. J Clin Endocrinol Metab 97: 987–994.CrossRefGoogle Scholar
  12. 12.
    Cullberg KB, Christiansen T, Paulsen SK, Bruun JM, Pedersen SB, Richelsen B, 2013 Effect of weight loss and exercise on angiogenic factors in the circulation and in adipose tissue in obese subjects. Obesity (Silver Spring) 21: 454–460.CrossRefGoogle Scholar
  13. 13.
    Khurana R, Moons L, Shafi S, et al, 2005 Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 111: 2828–2836.CrossRefGoogle Scholar
  14. 14.
    Christiaens V, Lijnen HR, 2010 Angiogenesis and development of adipose tissue. Mol Cell Endocrinol 318: 2–9.CrossRefGoogle Scholar
  15. 15.
    Lijnen HR, Christiaens V, Scroyen I, et al, 2006 Impaired adipose tissue development in mice with inactivation of placental growth factor function. Diabetes 55: 2698–2704.CrossRefGoogle Scholar
  16. 16.
    Siervo M, Ruggiero D, Sorice R, et al, 2010 Angiogenesis and biomarkers of cardiovascular risk in adults with metabolic syndrome. J Intern Med 268: 338–347.CrossRefGoogle Scholar
  17. 17.
    Pervanidou P, Akalestos A, Bastaki D, Apostolakou F, Papassotiriou I, Chrousos GP, 2013 Increased Circulating High Sensitivity-Troponin (hs-TnT) Concentrations in Children and Adolescents with Obesity and the Metabolic Syndrome: a Marker for Early Cardiac Damage? Metabolism 62: 527–531.CrossRefGoogle Scholar
  18. 18.
    Cole TJ, Bellizzi MC, Flegal KM, Dietz WH, 2000 Establishing a standard definition for child overweight and obesity worldwide: International survey. BMJ 320: 1240–1243.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Chiotis D, Krikos X, Tsiftis G, Hatzisymeaon M, Maniati-Christidi M, Dacou-Voutetakis C, 2004 Body mass index and prevalence of obesity in subjects of Hellenic origin aged 0–18years, living in the Athens area. Ann Clin Paediatr Univ Atheniensis 51: 139–154.Google Scholar
  20. 20.
    Zimmet P, Alberti KG, Kaufman F, et al, 2007 IDF Consensus Group. The metabolic syndrome in children and adolescents — an IDF consensus report. Pediatr Diabetes 8: 299–306.CrossRefGoogle Scholar
  21. 21.
    Tanner JM 1962 Growth at adolescence. 2nd ed. Oxford: Blackwell Scientific Publications.Google Scholar
  22. 22.
    Wallace TM, Levy JC, Matthews DR, 2004 Use and abuse of HOMA modeling. Diabetes Care 27: 1487–1495CrossRefGoogle Scholar
  23. 23.
    Pilarczyk K, Sattler KJ, Galili O, et al, 2008 Placenta growth factor expression in human atherosclerotic carotid plaques is related to plaque destabilization. Atherosclerosis 196: 333–340.CrossRefGoogle Scholar
  24. 24.
    Roy H, Bhardwaj S, Ylä-Herttuala S, 2006 Biology of vascular endothelial growth factors. FEBS Lett 580: 2879–2887.CrossRefGoogle Scholar
  25. 25.
    Wallace TW, Abdullah SM, Drazner MH, et al, 2006 Prevalence and determinants of troponin T elevation in the general population. Circulation 113: 1958–1965.CrossRefGoogle Scholar
  26. 26.
    Pervanidou P, Akalestos A, Sakka S, Kanaka-Gantenbein C, Papassotiriou I, Chrousos GP, 2010 Gender dimorphic associations between N-terminal pro-brain natriuretic peptide, body mass index and blood pressure in children and adolescents. Horm Res Paediatr 73: 341–348.CrossRefGoogle Scholar
  27. 27.
    Pervanidou P, Margeli A, Akalestos A, et al, 2009 Associations between circulating N-terminal pro-Brain Natriuretic Peptide (NT-proBNP) and adiponectin concentrations depend on obesity level in female adolescents: gender dimorphic findings. Horm Metab Res 41: 829–833.CrossRefGoogle Scholar
  28. 28.
    Sorice R, Ruggiero D, Nutile T, et al, 2012 Genetic and environmental factors influencing the Placental Growth Factor (PGF) variation in two populations. PLoS One 7: e42537.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Goodman E, Daniels SR, Meigs JB, Dolan LM, 2007 Instability in the diagnosis of metabolic syndrome in adolescents. Circulation 115: 2316–2322.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Huang K, Zou CC, Yang XZ, Chen XQ, Liang L, 2010 Carotid intima-media thickness and serum endothelial marker levels in obese children with metabolic syndrome. Arch Pediatr Adolesc Med 164: 846–851.PubMedGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2014

Authors and Affiliations

  • Panagiota Pervanidou
    • 1
    Email author
  • Giorgos Chouliaras
    • 1
  • Athanassios Akalestos
    • 2
  • Despoina Bastaki
    • 1
  • Filia Apostolakou
    • 2
  • Ioannis Papassotiriou
    • 2
  • George P. Chrousos
    • 1
    • 3
  1. 1.Childhood Obesity Clinic, Center of Developmental and Behavioral Pediatrics, First Department of PediatricsAthens University Medical School, Aghia Sophia Children’s HospitalAthensGreece
  2. 2.Department of Clinical BiochemistryAghia Sophia Children’s HospitalAthensGreece
  3. 3.Department of BiochemistryKing Abdulaziz UniversityJeddahSaudi Arabia

Personalised recommendations